Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs
President Trump signed a historic executive order fast-tracking FDA reviews of breakthrough psychedelic therapies to help our brave veterans heal from PTSD. This bold move prioritizes the mental well-being of those who served over bureaucratic red tape and radical activist agendas.
Written with the help of AI by Ghostwriter KIERO SWISS from the sources named in the article. About the author and how we write